Cargando…

Systemic AL amyloidosis: current approach and future direction

Systemic Light chain (AL) amyloidosis is a monoclonal plasma cell proliferative disorder characterized by deposition of amyloidogenic monoclonal light chain fragments causing organ dysfunction. It is a fatal disease and if not diagnosed and treated early can lead to organ failure and potentially dea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bou Zerdan, Maroun, Nasr, Lewis, Khalid, Farhan, Allam, Sabine, Bouferraa, Youssef, Batool, Saba, Tayyeb, Muhammad, Adroja, Shubham, Mammadii, Mahinbanu, Anwer, Faiz, Raza, Shahzad, Chaulagain, Chakra P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132994/ https://www.ncbi.nlm.nih.gov/pubmed/37185672 http://dx.doi.org/10.18632/oncotarget.28415

Ejemplares similares

Addendum: Systemic AL amyloidosis: current approach and future direction
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Multidisciplinary supportive care in systemic light chain amyloidosis
por: Maroun, Bou Zerdan, et al.
Publicado: (2022)

Liquid biopsies and minimal residual disease in lymphoid malignancies
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Liquid biopsies and minimal residual disease in myeloid malignancies
por: Allam, Sabine, et al.
Publicado: (2023)

A Synopsis Clonal Hematopoiesis of Indeterminate Potential in Hematology
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Utility of Bruton's Tyrosine Kinase Inhibitors in Light Chain Amyloidosis Caused by Lymphoplasmacytic Lymphoma (Waldenström's Macroglobulinemia)
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Metabolic Syndrome: Updates on Pathophysiology and Management in 2021
por: Fahed, Gracia, et al.
Publicado: (2022)

Single Cell RNA Sequencing: A New Frontier in Pancreatic Ductal Adenocarcinoma
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Predictors of Hospitalizations and Death from COVID-19 in Patients with Multiple Myeloma
por: Chaulagain, Chakra P, et al.
Publicado: (2022)

Challenges of Managing Multiple Myeloma Patients with Sickle Cell Disease: A Case Report and Review of Literature
por: Zerdan, Maroun Bou, et al.
Publicado: (2021)

Adhesion molecules in multiple myeloma oncogenesis and targeted therapy
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Insights of Medical Students and Graduates Toward Electronic Learning During the COVID-19 Pandemic in Lebanon: A National Cross-Sectional Study
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Fertility in multiple recurrent bilateral ovarian teratomas: A case report
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Microbial Influences on Immune Checkpoint Inhibitor Response in Melanoma: The Interplay between Skin and Gut Microbiota
por: Bouferraa, Youssef, et al.
Publicado: (2023)

Recent Advances in the Treatment and Supportive Care of POEMS Syndrome
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

COVID-19 vaccine immune response in patients with plasma cell dyscrasia: a systematic review
por: Faizan, Unaiza, et al.
Publicado: (2023)

Everolimus in poorly differentiated neuroendocrine carcinoma of unknown primary: A case report
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Risk of Venous Thromboembolism in Multiple Myeloma Patients During the Immediate Peri-Autologous Hematopoietic Cell Transplantation Phase
por: Awada, Hussein, et al.
Publicado: (2023)

Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Carbapenemase Inhibitors: Updates on Developments in 2021
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice
por: Dima, Danai, et al.
Publicado: (2023)

Role of circulating tumor DNA and circulating tumor cells in breast cancer: History and updates
por: Chedid, Julien, et al.
Publicado: (2022)

Oligodendroglioma: A Review of Management and Pathways
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

Fecal Microbiota Transplant for Hematologic and Oncologic Diseases: Principle and Practice
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

Cardiac Amyloidosis: A Rare Cause of Recurrent Chylothorax
por: Patel, Raj, et al.
Publicado: (2022)

Management of Primary Plasma Cell Leukemia Remains Challenging Even in the Era of Novel Agents
por: Chaulagain, Chakra P, et al.
Publicado: (2021)

Daratumumab-based Regimen in Treating Clonal Plasma Cell Neoplasms in Solid Organ Transplant Recipients
por: Chaulagain, Chakra P., et al.
Publicado: (2020)

Mechanisms of Immunotoxicity: Stressors and Evaluators
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

Overwhelming Asplenic Sepsis due to Babesiosis
por: Chaulagain, Chakra P.
Publicado: (2019)

The Lung Microbiota and Lung Cancer: A Growing Relationship
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

The Urogenital System’s Role in Diseases: A Synopsis
por: Zerdan, Maroun Bou, et al.
Publicado: (2022)

Genomic Assays in Node Positive Breast Cancer Patients: A Review
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

Corrigendum: Genomic Assays in Node Positive Breast Cancer Patients: A Review
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

Olaratumab’s failure in soft tissue sarcoma
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges
por: Moubarak, Simon, et al.
Publicado: (2022)

Molecular Targets in Salivary Gland Cancers: A Comprehensive Genomic Analysis of 118 Mucoepidermoid Carcinoma Tumors
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Radiation Recall Dermatitis Following Treatment With Pembrolizumab: A Case Report and Review of the Literature
por: Sandhu, Michael, et al.
Publicado: (2023)

Addendum: Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (MTAP) loss
por: Bou Zerdan, Maroun, et al.
Publicado: (2023)

Management of Adverse Reactions for BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review
por: Khanam, Razwana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h224164giujpcid2jmo8t8tavq